Public consultation on applications to be considered by the MSAC PASC (August 2022)

Closes 8 Jul 2022

Opened 27 May 2022


Consultation is now open for applications that are anticipated to be considered by the PICO Advisory Sub-Committee (PASC) of the Medical Services Advisory Committee (MSAC) on 11-12 August 2022.

PASC values consultation input from individuals and organisations with an interest in an application that it is considering, including experience of the medical conditions, services or technologies being addressed by the application.   

It is anticipated that the below-mentioned applications will proceed to PASC in August 2022. Consultation input must be received by no later than Friday, 8 July 2022 for it to be considered by PASC. A consultation survey form is available on the relevant application webpage.

Further information on MSAC’s consultation process is also available on the MSAC website.

Applications scheduled to be considered:

New Applications:

1712 – Out-of-laboratory sleep studies in the diagnosis and management of sleep disordered breathing in children & adolescents

1713 – Cardiac MRI in the diagnosis of myocarditis

1717 – Extravascular implantable cardioverter therapy for patients at risk of ventricular arrhythmia

1719 – Insertion of a bioabsorbable implant for nasal airway obstruction due to lateral wall insufficiency

Update - 17 June 2022:

1710: Newborn bloodspot screening for X-linked adrenoleukodystrophy 

Please note that the Consultation closing date for Application 1710 is Friday, 22 July 2022.

How to provide input to MSAC

To provide input on any of the applications listed, please click on the relevant application link above this box. This will take you to the relevant MSAC webpage where you will be able to download and complete a consultation survey.

Alternatively, you can provide a separate file with your input to

Guidance on what sort of information to include in your consultation input can be found on the MSAC website. 

Consumers and consumer groups and organisations are welcome to contact the Consumer Evidence and Engagement Unit for questions on current consultations


  • Anyone from any background


  • All